Evidence map›Paper›PMID 35975150›Full record

ArticleChemical science2022

Access to chiral β-sulfonyl carbonyl compounds

Fu-Sheng He, Chun Zhang, Minghui Jiang, Lujun Lou, Jie Wu, Shengqing Ye

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. [3 + 2] Cycloadditions of Tertiary AmineACS organic & inorganic Au · 2026
    Article
  3. C(spNature communications · 2024
    Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Fu-Sheng HeSchool of Pharmaceutical and Materials Engineering & Institute for Advanced Studies, Taizhou University 1139 Shifu Avenue Taizhou 318000 China shengqing.ye@tzc.edu.cn jie_wu@fudan.edu.cn.
Chun ZhangSchool of Pharmaceutical and Materials Engineering & Institute for Advanced Studies, Taizhou University 1139 Shifu Avenue Taizhou 318000 China shengqing.ye@tzc.edu.cn jie_wu@fudan.edu.cn.
Minghui JiangSchool of Pharmaceutical and Materials Engineering & Institute for Advanced Studies, Taizhou University 1139 Shifu Avenue Taizhou 318000 China shengqing.ye@tzc.edu.cn jie_wu@fudan.edu.cn.
Lujun LouSchool of Pharmaceutical and Materials Engineering & Institute for Advanced Studies, Taizhou University 1139 Shifu Avenue Taizhou 318000 China shengqing.ye@tzc.edu.cn jie_wu@fudan.edu.cn.
Jie WuSchool of Pharmaceutical and Materials Engineering & Institute for Advanced Studies, Taizhou University 1139 Shifu Avenue Taizhou 318000 China shengqing.ye@tzc.edu.cn jie_wu@fudan.edu.cn.ORCID https://orcid.org/0000-0002-0967-6360
Shengqing YeSchool of Pharmaceutical and Materials Engineering & Institute for Advanced Studies, Taizhou University 1139 Shifu Avenue Taizhou 318000 China shengqing.ye@tzc.edu.cn jie_wu@fudan.edu.cn.ORCID https://orcid.org/0000-0002-6917-0505
Taizhou University · CNChinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An organocatalytic enantioselective radical reaction of potassium alkyltrifluoroborates, DABCO·(SO

Identifiers

PMID35975150
PMCPMC9350669
OpenAlexW4285284476

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.